Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
Clinical trial NCT05002413 · COMPLETED
Trial details
- NCT number
- NCT05002413
- Sponsor
- Resistell AG
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-18
- Primary completion
- 2024-02-19
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.